
Dinrab D 30mg/20mg Capsule SR
Marketer
Gadin Pharmaceuticals Pvt Ltd
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Dinrab D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with the combined medication, RelivAcid 30mg/20mg Extended-Release Capsules. This formulation alleviates common GERD symptoms such as heartburn, abdominal pain, and discomfort. It achieves this by neutralizing stomach acid and facilitating gas expulsion, thus easing stomach distress. RelivAcid 30mg/20mg Extended-Release Capsules should be taken on an empty stomach, following your physician's prescribed dosage and duration. Treatment length depends on your individual response and the severity of your condition; premature discontinuation may lead to symptom recurrence and condition exacerbation. Complete transparency with your healthcare provider regarding all other medications is crucial, as interactions are possible. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects to your doctor immediately. Drowsiness and dizziness are potential effects; avoid activities requiring alertness until the medication's impact is known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing treatment, inform your doctor of any existing kidney or liver conditions, and if you are pregnant, planning a pregnancy, or breastfeeding.
Primary Ingredients of Dinrab D 30mg/20mg Capsule SR
No text provided to rephrase.
Uses of Dinrab D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Dinrab D 30mg/20mg Capsule SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire capsule whole; avoid chewing, crushing, or fracturing it. Administer Dinrab D 30mg/20mg Sustained-Release Capsules on an empty stomach.
Common Side effects of Dinrab D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Dinrab D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire capsule without chewing, crushing, or fracturing. Administer Dinrab D 30mg/20mg Sustained-Release Capsules on an empty stomach.
How Dinrab D 30mg/20mg Capsule SR works:
Dinrab D SR capsules (30mg/20mg Domperidone/Rabeprazole) combine a prokinetic agent, Domperidone, with the proton pump inhibitor (PPI), Rabeprazole. Domperidone enhances upper gastrointestinal motility, facilitating smoother food passage. Rabeprazole decreases stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Dinrab D 30mg/20mg Capsule SR concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Prolonged-release Dinrab D 30mg/20mg capsules might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Dinrab D 30mg/20mg capsule is likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Dinrab D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Dinrab D 30mg/20mg sustained-release capsules cautiously. Dosage modifications for Dinrab D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Dinrab D 30mg/20mg sustained-release capsules. Dosage modification may be necessary; physician consultation is advised. Dinrab D 30mg/20mg sustained-release capsules are contraindicated in patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Dinrab D 30mg/20mg Capsule SR :
Should you forget a Dinrab D 30mg/20mg SR Capsule dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dinrab D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
